trending Market Intelligence /marketintelligence/en/news-insights/trending/cujwe9um2yrvifmyuuwwcq2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Gujarat Themis Biosyn appoints director


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Gujarat Themis Biosyn appoints director

Gujarat Themis Biosyn Ltd. appointed Namjin Park as an additional director of the Indian drugmaker.

Park will be representing Yuhan Corp. on the board. He has been working with Yuhan Corp. since 1994 and was designated as executive director in April.

Hinesh Doshi will be an alternate director to Park. He is a senior partner at Hinesh R. Doshi and Co LLP.